Call it a movement, a philosophy, a revelation or a revolution.
Call it “one medicine,” “one health” or “zoobiquity.”
Call it something new, or—given that the “aha” moment on which the concept is based came in the 19th century—call it something old that’s been remembered and repackaged amidst the growing awareness that solving the mysteries of animal diseases and disorders, from injured spinal cords to cancer, can lead to possibly curing our own.
Over at least the past five years, there has been a rekindled recognition of the species-spanning nature of diseases, and of the value of species-spanning research. About 75 percent of recently emerging infectious diseases that affect humans have their origins in animals, according to the Centers for Disease Control.
On a theoretical level, the concept of “zoobiquity,” a term coined in the 2012 book of the same name, suggests that, no matter our species, we’re all in this together, subject to most of the same infirmities, capable of passing a lot of them back and forth, and more likely to find cures and treatments if we look at the big picture—at the earth and all its creatures —as opposed to focusing solely on humans.
On a practical level, species-spanning thinking—referred to by various monikers—has led in recent years to veterinary schools reinventing themselves; to a heightened spirit of cooperation between doctors and veterinarians; to new sources of funding for research; and to the realization that, when it comes to diseases shared by humans and animals, the latter may provide a quicker and less expensive route to a cure for all.
Where do dogs fit in? Right at the top. No other animal—if not physiologically, at least in terms of sharing our genetic markers and our home environment—is as close to us.
That’s why Texas A&M veterinarians and University of California, San Francisco, medical researchers have teamed up to study spinal problems in Dachshunds and other dwarf breeds and to test a new drug that blocks secondary infections. The research, which is funded by the Department of Defense, has potential application to battlefield injuries
That’s why, in New York, veterinarians with the Animal Medical Center have joined forces with physicians and researchers at the Memorial Sloan-Kettering Cancer Center to set up trials in which electrical impulses are used to treat tumors of the urinary tract in canines, with an eye toward possible human application.
That’s why the Mayo Clinic has partnered with two veterinary schools, a medical school and a private corporation to study the effectiveness of a device aimed at predicting and controlling epileptic seizures in both dogs and humans. While traditionally, research into canine epilepsy has been funded primarily by the American Kennel Club’s Canine Health Foundation and breed clubs, the Mayo Clinic collaboration received a $7.5 million grant from the National Institutes of Health.
That’s why Tobi, a paralyzed Golden Retriever, is getting stem-cell treatments that may help him walk again as part of a clinical trial headed by Dr. Natasha Olby, veterinarian and neurologist at North Carolina State University’s (NCSU) College of Veterinary Medicine. The trial will involve as many as 30 dogs over three years.
And that’s why Peggy, a Chihuahua from Albuquerque who was born with three legs, is being outfitted with a “bionic” paw at NCSU. Implanting the prosthetic device, which will have electrodes that connect to her nerves, will allow her to run and scratch, and could add to the growing use of comparable technology in humans.